ATE219367T1 - Verfahren zur senkung des augeninnendrucks im auge von säugern unter anwendung von muskarinantagonisten - Google Patents
Verfahren zur senkung des augeninnendrucks im auge von säugern unter anwendung von muskarinantagonistenInfo
- Publication number
- ATE219367T1 ATE219367T1 AT93907541T AT93907541T ATE219367T1 AT E219367 T1 ATE219367 T1 AT E219367T1 AT 93907541 T AT93907541 T AT 93907541T AT 93907541 T AT93907541 T AT 93907541T AT E219367 T1 ATE219367 T1 AT E219367T1
- Authority
- AT
- Austria
- Prior art keywords
- alpha
- methyl
- piperidinyl
- dihydro
- benzodiazepin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/853,374 US5716952A (en) | 1992-03-18 | 1992-03-18 | Method for reducing intraocular pressure in the mammalian eye by administration of muscarinic antagonists |
PCT/US1993/002403 WO1993018772A1 (en) | 1992-03-18 | 1993-03-16 | Method for reducing intraocular pressure in the mammalian eye by administration of muscarinic antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE219367T1 true ATE219367T1 (de) | 2002-07-15 |
Family
ID=25315868
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93907541T ATE219367T1 (de) | 1992-03-18 | 1993-03-16 | Verfahren zur senkung des augeninnendrucks im auge von säugern unter anwendung von muskarinantagonisten |
Country Status (8)
Country | Link |
---|---|
US (1) | US5716952A (de) |
EP (1) | EP0634932B1 (de) |
JP (1) | JPH07504915A (de) |
AT (1) | ATE219367T1 (de) |
AU (1) | AU666536B2 (de) |
DE (1) | DE69332048T2 (de) |
ES (1) | ES2177543T3 (de) |
WO (1) | WO1993018772A1 (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000229961A (ja) | 1998-12-11 | 2000-08-22 | Sagami Chem Res Center | ヒドロナフト[2,3−c]フラン誘導体およびその製造方法 |
US6063847A (en) * | 1997-11-25 | 2000-05-16 | Schering Corporation | Thrombin receptor antagonists |
US6528529B1 (en) | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
US6164282A (en) * | 1999-01-27 | 2000-12-26 | Allergan Sales, Inc. | Methods for restoring and/or enhancing accommodation in pseudo phakia |
AU2002335031C1 (en) * | 2001-10-18 | 2006-11-16 | Schering Corporation | Himbacine analogues as thrombin receptor antagonists |
CA2573674A1 (en) | 2004-07-16 | 2006-01-26 | Proteosys Ag | Muscarinic antagonists with parp and sir modulating activity as agents for inflammatory diseases |
WO2010081823A1 (en) | 2009-01-13 | 2010-07-22 | Proteosys Ag | Pirenzepine as otoprotective agent |
SG192648A1 (en) * | 2011-02-09 | 2013-09-30 | Singapore Health Serv Pte Ltd | Transglutaminase-2 inhibitors and uses thereof |
US9421199B2 (en) | 2014-06-24 | 2016-08-23 | Sydnexis, Inc. | Ophthalmic composition |
WO2016172712A2 (en) | 2015-04-23 | 2016-10-27 | Sydnexis, Inc. | Ophthalmic composition |
US11382909B2 (en) * | 2014-09-05 | 2022-07-12 | Sydnexis, Inc. | Ophthalmic composition |
US11052094B2 (en) | 2015-05-29 | 2021-07-06 | Sydnexis, Inc. | D2O stabilized pharmaceutical formulations |
KR102281667B1 (ko) | 2017-05-11 | 2021-07-23 | 네바카 아이엔씨. | 아트로핀 약학 조성물 (atropine pharmaceutical compositions) |
AU2018371787A1 (en) * | 2017-11-21 | 2020-11-05 | Sydnexis, Inc. | Ophthalmic composition and delivery device thereof |
CA3189821A1 (en) | 2020-08-04 | 2022-02-10 | Santen Pharmaceutical Co., Ltd. | Agent for treating myopia, preventing myopia and/or suppressing myopia progression |
JP7062846B1 (ja) * | 2020-10-14 | 2022-05-06 | 参天製薬株式会社 | 安定な医薬組成物 |
TW202402753A (zh) * | 2022-03-30 | 2024-01-16 | 日商參天製藥股份有限公司 | 高純度化合物之製造方法及純化方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2918407A (en) * | 1957-04-08 | 1959-12-22 | Lakeside Lab Inc | Anti-spasmodics specific for upper gastrointestinal pain and spasm |
US3467756A (en) * | 1967-03-16 | 1969-09-16 | Merck & Co Inc | Composition and method for treating glaucoma |
DE1795183B1 (de) * | 1968-08-20 | 1972-07-20 | Thomae Gmbh Dr K | 5,11-Dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-on-derivate und Arzneimittel |
US4197301A (en) * | 1978-10-16 | 1980-04-08 | Allergan Pharmaceuticals, Inc. | Topical ophthalmic use of Prazosin |
US4565821A (en) * | 1983-03-21 | 1986-01-21 | The Texas A&M University System | Method and ophthalmic composition for treating ocular hypertension and glaucoma with butyrophenones |
IT1212742B (it) * | 1983-05-17 | 1989-11-30 | Dompe Farmaceutici Spa | Derivati dibenzo [1,4]diazepinonici pirido [1,4] benzodiazepinonici,pirido [1,5] benzodiazepinonici e loro attivita' farmacologica |
DE3409237A1 (de) * | 1984-03-14 | 1985-09-19 | Dr. Karl Thomae Gmbh, 7950 Biberach | Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
US4886815A (en) * | 1984-06-20 | 1989-12-12 | Schachar Ronald A | Treatment and prevention of retinal edema with dopaminergic antagonists |
DE3626095A1 (de) * | 1986-07-31 | 1988-02-11 | Thomae Gmbh Dr K | Neue substituierte pyrido(2,3-b)(1,4)benzodiazepin-6-one, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
JP3165436B2 (ja) * | 1989-06-21 | 2001-05-14 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルベニア | 眼の発達の治療及び制御 |
US5066664A (en) * | 1990-02-28 | 1991-11-19 | Allergan, Inc. | 2-(hydroxy-2-alkylphenylamino)-oxazolines and thiazolines as anti-glaucoma and vasoconstrictive agents |
US5091528A (en) * | 1990-09-12 | 1992-02-25 | Allergan, Inc. | 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as α adrenergic agents |
US5153205A (en) * | 1990-10-01 | 1992-10-06 | Merck & Co., Inc. | Method to reduce introacular pressure without causing miosis |
-
1992
- 1992-03-18 US US07/853,374 patent/US5716952A/en not_active Expired - Fee Related
-
1993
- 1993-03-16 JP JP5516681A patent/JPH07504915A/ja active Pending
- 1993-03-16 AT AT93907541T patent/ATE219367T1/de not_active IP Right Cessation
- 1993-03-16 AU AU38109/93A patent/AU666536B2/en not_active Ceased
- 1993-03-16 WO PCT/US1993/002403 patent/WO1993018772A1/en active IP Right Grant
- 1993-03-16 EP EP93907541A patent/EP0634932B1/de not_active Expired - Lifetime
- 1993-03-16 DE DE69332048T patent/DE69332048T2/de not_active Expired - Fee Related
- 1993-03-16 ES ES93907541T patent/ES2177543T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0634932A1 (de) | 1995-01-25 |
AU3810993A (en) | 1993-10-21 |
WO1993018772A1 (en) | 1993-09-30 |
ES2177543T3 (es) | 2002-12-16 |
EP0634932B1 (de) | 2002-06-19 |
US5716952A (en) | 1998-02-10 |
JPH07504915A (ja) | 1995-06-01 |
AU666536B2 (en) | 1996-02-15 |
DE69332048D1 (de) | 2002-07-25 |
DE69332048T2 (de) | 2003-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE219367T1 (de) | Verfahren zur senkung des augeninnendrucks im auge von säugern unter anwendung von muskarinantagonisten | |
US6534496B1 (en) | Thermogenic composition and benzazepine thermogenics | |
US5096890B1 (en) | Pyrrolidine derivatives | |
KR910009700A (ko) | 3-피페리디닐-1,2-벤즈이속사졸 | |
ES8609309A1 (es) | Un nuevo procedimiento para la preparacion de nuevos derivados. de carbazolona. | |
PE20030848A1 (es) | Compuestos de espiropiperidina n-sustituidos como ligandos para el receptor orl-1 | |
ATE213631T1 (de) | Benzo- und pyridopyranderivate mit anxiolytischer und antikonvulsiver aktivität | |
JPH0692405B2 (ja) | 三環式ピリジン誘導体 | |
FI95912C (fi) | Menetelmä terapeuttisesti aktiivisten pyrido/2,3-f//1,4/tiatsepiini- ja pyrido/3,2-b//1,5/bentsotiatsepiinijohdannaisten valmistamiseksi | |
US4710504A (en) | Anti-depressant spiro hexahydro arylquinolizine derivatives, composition, and method of use therefor | |
DE69129165D1 (de) | Prozess zur Darstellung von Lactamderivaten | |
CA2132007A1 (en) | Method for reducing intraocular pressure in the mammalian eye by administration of muscarinic antagonists | |
US4604388A (en) | Fused aromatic oxazepinones, thiazepinones, diazepinones and sulfur analogs thereof in a method of counteracting histamine | |
KR890011886A (ko) | 축합된 디아제피논, 이의 제조방법 및 이를 함유하는 약제학적 조성물 | |
US4824849A (en) | α2 -adrenoceptor antagonistic arylquinolizines | |
RU99123631A (ru) | Соли оптически активного сульфоксидного производного | |
KR930702976A (ko) | 울증 및 조중의 치료에 있어서의 특정 글루타르이미드 유도체의 용도 | |
TH34036A (th) | วิธีสำหรับการควบคุมสูตรเครื่องหมาย trkA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |